Answers are grounded in this paper and cite their sources.
Coronavirus Disease 2019 or known as COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In the virus, there is 3C-like Protease which is a non-structural protein in SARS-CoV-2. These proteins are responsible for the process of translation and viral replication. alpha -spinasterol is a sterol compound in trembesi seeds (Samanea saman (jacq.) Merr) which functions to increase immunity. The purpose of this study was to determine the potential of the alpha-spinasterol compound in trembesi seeds (Samanea saman (jacq.) Merr) as an inhibitor of the 3C-like Protease SARS-CoV-2 with PDB ID: 6M2N using the in silico test. The type of research in this research is computer-based experimental research using in silico tests or molecular docking. The working procedure in this study is molecular docking by comparing the alpha-spinasterol compound in trembesi seeds (Samanea saman (jacq.) Merr) and the comparison compound lopinavir with a protein target of 3C-like Protease SARS-CoV-2 and predicting its physicochemical properties. The results of the in silico test showed that the free bond energy was -8.4 kcal/mol and smaller than the comparison compound lopinavir (-8.2 kcal/mol). The amino acid residues in alpha-spinasterol are Asn203, Gly109, Pro108, Gln107, Gln110, Pro293, and Leu202 which have similar acid residues to lopinavir on compound binding to the 3CL-like Protease from SARS-CoV-2. Meanwhile, based on the Lipinski Rule of Five law, the alpha spinasterol compound still meets the requirements if it will be used as a new drug compound so that alternative drugs can be used to replace lopinavir
No takes yet. Share an insight, caveat, or question.
Muh. Shofi (2022) studied this question.
Synapse has enriched one related paper. Consider it for comparative context: